Salts

US9926305B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Britta Olenik · Bottrop, DE
• Birgit Keil · Düsseldorf, DE
• Martin-Holger Hinz · Hückeswagen, DE
• Chantal Fürstner · Neheim, DE
• Mario Jeske · Solingen, DE
• Jens Ackerstaff · Mülheim an der Ruhr, DE

Key dates

• Filing date: Nov 5, 2014
• Grant date: Mar 27, 2018
• Expiry date: Nov 5, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Salts of 1-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1R)-4-(trifluoromethyl) -2,3-dihydro-1H-inden-1-yl]-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid of the formula (I), in particular amino acid salts such as the lysine salt and alkali metal salts such as the sodium salt and the potassium salt, processes for their preparation, medicaments comprising them and their use for controlling diseases.